EcoDrugPlus

Transmembrane O-Methyltransferase-Like

Ensembl ID : ENSPNYG00000001281
Gene Symbol: LOC102201493
2 Cross references
177 Possible Orthologues:

Tryptophan 5-Hydroxylase 1-Like

Ensembl ID : ENSPNYG00000020110
Gene Symbol: LOC102210596
3 Cross references
176 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSPNYG00000019227
Gene Symbol: TPH1
3 Cross references
207 Possible Orthologues:

Tubulin Alpha-1c Chain-Like

Ensembl ID : ENSPNYG00000012570
Gene Symbol: LOC102201029
2 Cross references
170 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSPNYG00000008775
Gene Symbol: TUBB
3 Cross references
106 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSPNYG00000022585
Gene Symbol: TUBB
2 Cross references
173 Possible Orthologues:

Tubulin Beta-2a Chain-Like

Ensembl ID : ENSPNYG00000013382
Gene Symbol: LOC102202611
3 Cross references
305 Possible Orthologues:

Tubulin, Alpha 7 Like

Ensembl ID : ENSPNYG00000020869
Gene Symbol: TUBA7L
1 Cross references
575 Possible Orthologues:

Type-2 Angiotensin Ii Receptor-Like

Ensembl ID : ENSPNYG00000000126
Gene Symbol: LOC102208181
3 Cross references
185 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSPNYG00000023229
Gene Symbol: TYR
4 Cross references
198 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSPNYG00000013939
Gene Symbol: TYR
3 Cross references
202 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSPNYG00000015595
Gene Symbol: TH
3 Cross references
187 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).